Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 877,700 | 712,800 | 451,300 | 213,000 | 747,100 |
| Depreciation Amortization | 681,100 | 508,100 | 337,100 | 166,800 | 643,500 |
| Income taxes - deferred | 97,600 | 76,400 | -12,200 | -6,100 | -20,100 |
| Accounts receivable | -122,200 | -126,500 | -135,100 | -166,900 | -21,900 |
| Accounts payable and accrued liabilities | -52,800 | -204,400 | -80,600 | -147,600 | 72,100 |
| Other Working Capital | -526,100 | -516,900 | -349,500 | -436,600 | -154,100 |
| Other Operating Activity | 685,200 | 576,800 | 428,100 | 395,900 | 319,200 |
| Operating Cash Flow | $1,640,500 | $1,026,300 | $639,100 | $18,500 | $1,585,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -185,500 | N/A | N/A | N/A | -55,000 |
| PPE Investments | -426,500 | -307,100 | -201,500 | -125,500 | -487,900 |
| Net Acquisitions | -582,000 | -324,000 | -63,500 | -53,500 | -823,900 |
| Purchase Of Investment | N/A | -179,900 | -172,000 | -157,000 | N/A |
| Sale Of Investment | N/A | 6,900 | 6,900 | N/A | N/A |
| Investing Cash Flow | $-1,194,000 | $-804,100 | $-430,100 | $-336,000 | $-1,366,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 64,800 | 64,800 | 64,800 | 64,800 | 4,463,700 |
| Debt Repayment | -1,064,800 | -1,064,800 | -1,064,800 | -1,064,800 | -3,463,700 |
| Common Stock Issued | 54,300 | 54,300 | 25,700 | 25,700 | 56,200 |
| Common Stock Repurchased | -450,000 | -225,000 | -200,000 | N/A | -250,100 |
| Dividend Paid | -240,700 | -181,400 | -121,500 | -61,600 | -243,100 |
| Other Financing Activity | 179,400 | 185,500 | 188,700 | 196,200 | 216,900 |
| Financing Cash Flow | $-1,457,000 | $-1,166,600 | $-1,107,100 | $-839,700 | $779,900 |
| Exchange Rate Effect | 24,100 | 23,800 | 26,700 | 7,900 | -17,000 |
| Beginning Cash Position | 1,518,700 | 1,518,700 | 1,518,700 | 1,518,700 | 536,800 |
| End Cash Position | 532,300 | 598,100 | 647,300 | 369,400 | 1,518,700 |
| Net Cash Flow | $-986,400 | $-920,600 | $-871,400 | $-1,149,300 | $981,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,640,500 | 1,026,300 | 639,100 | 18,500 | 1,585,800 |
| Capital Expenditure | -434,500 | -310,600 | -203,900 | -126,000 | -489,900 |
| Free Cash Flow | 1,206,000 | 715,700 | 435,200 | -107,500 | 1,095,900 |